Targeting the diagnostic odyssey in rare disease care

Potential time reduction to diagnosis*

Neurodegenerative disease

up to 6 years

Metabolic disease

up to 10 years

Hypereosinophilic diseases

up to 12 years

Skeletal & Cardiac muscle

disease

up to 15 years

Ultrarare Inflammatory disease

up to 13.5 years

*If MiRare’s predictive AI PoC tool had been used during standard patient visits alongside the normal care process,

and the patient had been sent for specialist assessment

when MiRare indicated a corresponding rare disease.

(Based on in silico modelling and observational studies

using peer reviewed published medical case reports)

Reach out to our team for any inquiries:

See what MiRare can do for you: